Top Research Reports for Abbott, BlackRock & ConocoPhillips

Zacks11-28

Wednesday, November 27, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486801034?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/LGfEGHySJDFknqJ6h791Rg--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/07898017c06d55a392c4649155ab41b2","is_english":true,"pubTime":"2024-11-28 02:24","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2486801034","market":"us","top_or_hot":-1,"title":"Top Research Reports for Abbott, BlackRock & ConocoPhillips","media":"Zacks","content":"<div>\n<p>Wednesday, November 27, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott ...</p>\n\n<a href=\"https://finance.yahoo.com/news/top-research-reports-abbott-blackrock-182400037.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Research Reports for Abbott, BlackRock & ConocoPhillips</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Research Reports for Abbott, BlackRock & ConocoPhillips\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-28 02:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/top-research-reports-abbott-blackrock-182400037.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wednesday, November 27, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott ...</p>\n\n<a href=\"https://finance.yahoo.com/news/top-research-reports-abbott-blackrock-182400037.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1721428933.USD","symbol_name":"法巴全球经典环境基金RH MD Dis","start_time":0,"source_url":"https://finance.yahoo.com/news/top-research-reports-abbott-blackrock-182400037.html","article_id":"2486801034","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/LGfEGHySJDFknqJ6h791Rg--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/07898017c06d55a392c4649155ab41b2"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486801034","pubTimestamp":1732731840,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Abbottshares have outperformed the Zacks Medical sector  this year, but have lagged the S&P 500 index over the same time period .The Zacks analyst believes that Alinity, the company’s next-generation suite of systems, is a key driver in the core lab diagnostics business. EPD's impressive performance stems from the company’s unique business model. Freestyle Libre CGM device is also on a great trajectory. Within Nutrition, despite softness in global pediatric arm, Abbott is regaining market share banking on strong Adult Nutrition business.However, the significant runoff of COVID-19 testing-related sales is hurting Abbott’s Diagnostics growth. Tough macro conditions also remain a headwind.Shares of NetSol have outperformed the Zacks Computer – Software industry over the past year . Per the Zacks analyst, rebranding of the company’s product platform under the Transcend umbrella, and incorporation of advan","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","LU0426412945.USD":"NINETY ONE GSF GLOBAL FRANCHISE \"A\" (USD) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","PM":"菲利普莫里斯","OPXS":"Optex Systems Holdings, Inc.","COP":"康菲石油","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","AWK":"美国水务","BK4135":"资产管理与托管银行","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","TTE":"道达尔","LU2360107671.USD":"BGF FINTECH \"A4\" (USD) INC","ST":"Sensata Technologies Holding","LU2089279066.USD":"ALLIANZ GLOBAL WATER \"AT\" (USD) ACC","BK4213":"石油与天然气的勘探与生产","LU1633808545.USD":"ALLIANZ GLOBAL EQUITY GROWTH \"AT\" (USD) ACC","IE00B3CCJ963.GBP":"GUINNESS GLOBAL ENERGY \"C\" (GBP) ACC","COF":"第一资本","WSO":"华斯科","BK4592":"伊斯兰概念","LU2229751404.USD":"ALLIANZ GLOBAL WATER \"AT3\" (USD) ACC","IE0008368304.USD":"STEWART INVESTORS WORLDWIDE LEADERS SUSTAINABILITY FUND \"I\" (USD) ACC","SYF":"Synchrony Financial","CPAY":"Corpay","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","NTNX":"Nutanix Inc.","BK4585":"ETF&股票定投概念","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","NTWK":"奈特阳科技","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0345781412.USD":"NINETY ONE GSF GLOBAL NATURAL RESOURCES \"A\" (USD) INC","BLK":"贝莱德","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","ABT":"雅培","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4082":"医疗保健设备","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","PKG":"美国包装公司","LU0742537680.HKD":"FIDELITY GLOBAL DIVIDEND \"A \" (HKD) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","ITW":"伊利诺伊机械","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU1543694498.USD":"法巴水资源基金RH MD Dis"},"translate_title":"雅培、贝莱德和康菲石油公司的热门研究报告","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AWK":1,"WSO":1,"TTE":1,"SYF":1,"ST":1,"PM":1,"PKG":1,"OPXS":1,"NTWK":1,"NTNX":1,"ITW":1,"BLK":1,"CPAY":1,"COF":1,"COP":1,"ABT":1},"content_text":"Wednesday, November 27, 2024\nThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BlackRock, Inc. (BLK) and ConocoPhillips (COP), as well as two micro-cap stocks, NetSol Technologies, Inc. (NTWK) and Optex Systems Holdings, Inc (OPXS). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>\nAbbott shares have outperformed the Zacks Medical sector (+7.2% vs. +0.5%) this year, but have lagged the S&P 500 index over the same time period (+7.2% vs. +26.5%). \nThe Zacks analyst believes that Alinity, the company’s next-generation suite of systems, is a key driver in the core lab diagnostics business. EPD's impressive performance stems from the company’s unique business model. Freestyle Libre CGM device is also on a great trajectory. Within Nutrition, despite softness in global pediatric arm, Abbott is regaining market share banking on strong Adult Nutrition business.\nHowever, the significant runoff of COVID-19 testing-related sales is hurting Abbott’s Diagnostics growth. Tough macro conditions also remain a headwind.\n(You can read the full research report on Abbott here >>>)\nBlackRock shares have underperformed the Zacks Financial - Investment Management industry over the past year (+39.3% vs. +59.7%). The Zacks analyst believes that high operating expenses have been hurting BlackRock’s profitability. Its reliance on overseas revenues exposes it to geopolitical tensions, different regulatory/economic environments and exchange rate fluctuation.\nYet, efforts to restructure active equity business and strengthen private markets capabilities are expected to support top-line growth. The planned acquisition of Preqin, along with the buyouts of Global Infrastructure Partners and a stake in SpiderRock should also aid.\n(You can read the full research report on BlackRock here >>>)\nShares of ConocoPhillips have underperformed the Zacks Oil and Gas – Integrated – United States industry over the past year (-7.1% vs. -5.7%). Per the Zacks analyst, the company’s significant dependence on crude oil makes it vulnerable to market fluctuations. Additionally, inflationary pressures contributed to a significant increase in production and operating expenses in the last quarter, thereby squeezing margins.\nHowever, the impending acquisition of Marathon Oil Corporation should expand its regional footprint. ConocoPhillips is also strategically increasing its presence in the liquefied natural gas market to meet growing energy transition demands.\n(You can read the full research report on ConocoPhillips here >>>)\nShares of NetSol have outperformed the Zacks Computer – Software industry over the past year (+22.6% vs. +16.6%). Per the Zacks analyst, rebranding of the company’s product platform under the Transcend umbrella, and incorporation of advanced AI and machine learning capabilities have benefited the company. Also, NetSol has been aided by the renewal of a five-year support contract in China and a new agreement with a U.K.-based finance company.\nYet, costs of the development of products and services and global macroeconomic headwinds remain a concern.\n(You can read the full research report on NetSol here >>>)\nOptex’s shares have underperformed the Zacks Aerospace – Defense Equipment industry over the past year (-84.6% vs. +63.4%). The Zacks analyst believes that risks include margin compression due to inflationary pressures, contract concentration and competition from larger defense contractors have ailed the company.\nHowever, strategic contract wins bolster its positioning in the defense sector, where it aligns well with the growing demand for optical sighting systems and assemblies.\n(You can read the full research report on Optex here >>>)\nOther noteworthy reports we are featuring today include Philip Morris International Inc. (PM), TotalEnergies SE (TTE) and Illinois Tool Works Inc. (ITW).Director of ResearchSheraz MianNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>\nToday's Must Read\nRobust Diagnostics Business, EPD Gains Aid Abbott (ABT)\nBuyouts, AUM, Enhanced Capabilities Support BlackRock (BLK)\nConocoPhillips' (COP) Low-Cost & Diverse Upstream Assets Aid\nFeatured Reports\nTEVA's New Drugs & Generic Stability Are Reviving GrowthThe Zacks analyst believes newer drugs, Austedo and Ajovy as well as a stable generics business are reviving its top-line growth.\nExpanding LNG & Clean Energy Assets Aid TotalEnergies (TTE)Per the Zacks analyst TotalEnergies' presence in entire LNG value chain and expansion of clean energy generation through joint venture and acquisition will boost its performance.\nCorpay (CPAY) Grows Organically, High Interest Expense AilPer the Zacks analyst, Corpay's organic growth is fueled by rise in volume and revenues per transaction in its payment programs. Rising interest expense affects bottom-line.\nCards, Rates Support Capital One (COF), Asset Quality WeakPer the Zacks analyst, strength in credit card business, relatively high interest rates, decent loan demand and strategic buyouts will aid Capital One amid poor asset quality and rising expenses.\nPhilip Morris (PM) Benefits from Strong Smoke-free RevenuesPer the Zacks analyst, Philip Morris' smoke-free transition keeps it well-positioned for growth. Smoke-free products generated about 38% of the company's net revenues in the third quarter of 2024.\nInvestment & Expanding Operation Aid American Water (AWK)Per the Zacks analyst American Water's planned long-term investment to strengthen infrastructure and expanding operation through acquisition and organic means are going to drive its performance.\nAutomotive OEM Unit Aids Illinois Tool (ITW) Amid Forex WoesPer the Zacks analyst, Illinois Tool is benefiting from its Automotive OEM unit, driven by strength in the electric vehicle and Chinese OEM markets. However, forex woes are an added concern.\nNew Upgrades\nSolid Demand & Investments Aid Packaging Corporation (PKG)Per the Zacks analyst, Packaging Corp will gain on strong packaging demand driven by e-commerce and the need for food, beverages and medicines and its ongoing investments to boost production.\nSynchrony's (SYF) Strategic Buyouts and Collaborations AidPer the Zacks analyst, Synchrony's acquisitions will strengthen its digital capabilities & diversify the business. Also, its CareCredit platform demonstrates strong growth potential.\nDigital Transformation, Product Strength Aids Nutanix (NTNX)Per the Zacks analyst, Nutanix is benefiting from higher investments by clients in digital transformation, as well as frequent product refreshes which help it gain new customers.\nNew Downgrades\nSoft Traffic at NIKE Digital & China Hurt NIKE's (NKE) SalesPer the Zacks analyst, pronounced traffic softness at NIKE Digital and its partner stores in Greater China, led to lower-than-planned retail sales for NIKE, including wholesale partners.\nSluggish Construction Market Hurts Sensata's (ST) ProspectsPer the Zacks analyst, a soft housing construction market affects the Sensing Solutions unit's sales. Loss of market share to local OEMs in the Chinese market is a woe.\nPricing & Sales Mix, Higher Fixed Costs Hurt Watsco (WSO)Per the Zacks analyst, negative impact of pricing and sales mix for HVAC equipment as well as increase in fixed cost hurt Watsco's margin.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nIllinois Tool Works Inc. (ITW) : Free Stock Analysis Report\nAbbott Laboratories (ABT) : Free Stock Analysis Report\nConocoPhillips (COP) : Free Stock Analysis Report\nBlackRock, Inc. (BLK) : Free Stock Analysis Report\nPhilip Morris International Inc. (PM) : Free Stock Analysis Report\nTotalEnergies SE Sponsored ADR (TTE) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486801034"}